Chronic ischemic heart disease

Citations 1-8 of 8 total displayed.

Most recent content (1 Aug 2009):

Original Articles
CACNA1C Gene Polymorphisms, Cardiovascular Disease Outcomes, and Treatment Response

Amber L. Beitelshees, Hrishikesh Navare, Danxin Wang, Yan Gong, Jennifer Wessel, James I. Moss, Taimour Y. Langaee, Rhonda M. Cooper-DeHoff, Wolfgang Sadee, Carl J. Pepine, Nicolas J. Schork, and Julie A. Johnson
Circ Cardiovasc Genet 2009;2:362-370; published online before print as doi:10.1161/CIRCGENETICS.109.857839 [Abstract] [Full text]  

Original Articles
Prolactin Levels and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women

Anne Q. Reuwer, Marcel ThB Twickler, Barbara A. Hutten, Frederique W. Molema, Nicholas J. Wareham, Geesje M. Dallinga-Thie, Roman L. Bogorad, Vincent Goffin, Mijke Smink-Bol, John J.P. Kastelein, S. Matthijs Boekholdt, and Kay-Tee Khaw
Circ Cardiovasc Genet 2009;2:389-395; published online before print as doi:10.1161/CIRCGENETICS.109.853572 [Abstract] [Full text]  

Past content (since Feb 2009):

Original Article
Prolactin Levels and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women. A prospective case–control study nested in the Epic–Norfolk cohort.

Anne Q. Reuwer, Marcel Th. B. Twickler, Barbara A. Hutten, Frederique W. Molema, Nicholas J. Wareham, Geesje M. Dallinga–Thie, Roman L. Bogorad, Vincent Goffin, Mijke Smink–Bol, John J.P. Kastelein, S.Matthijs Boekholdt, and Kay–Tee Khaw
Circ Cardiovasc Genet published June 23, 2009, doi:10.1161/CIRCGENETICS.109.853572 [Abstract]  

Original Article
CACNA1C gene polymorphisms, cardiovascular disease outcomes and treatment response

Amber L. Beitelshees, Hrishikesh Navare, Danxin Wang, Yan Gong, Jennifer Wessel, James Moss, Taimour Y. Langaee, Rhonda M. Cooper–DeHoff, Wolfgang Sadee, Carl J. Pepine, Nicolas J. Schork, and Julie A. Johnson
Circ Cardiovasc Genet published June 3, 2009, doi:10.1161/CIRCGENETICS.109.857839 [Abstract]  

Editorial
The Report Card on Growth Differentiation Factor 15: Consistent Marks But Not Yet Ready for Promotion

Anand Rohatgi and James A. de Lemos
Circ Cardiovasc Genet 2009;2:209-211, doi:10.1161/CIRCGENETICS.109.874511 [Full text]  

Original Articles
Growth-Differentiation Factor-15 for Risk Stratification in Patients With Stable and Unstable Coronary Heart Disease: Results From the AtheroGene Study

Tibor Kempf, Jan-Malte Sinning, Anja Quint, Christoph Bickel, Christoph Sinning, Philipp S. Wild, Renate Schnabel, Edith Lubos, Hans J. Rupprecht, Thomas Münzel, Helmut Drexler, Stefan Blankenberg, and Kai C. Wollert
Circ Cardiovasc Genet 2009;2:286-292; published online before print as doi:10.1161/CIRCGENETICS.108.824870 [Abstract] [Full text]  

Original Article
Growth-Differentiation Factor-15 for Risk Stratification in Patients with Stable and Unstable Coronary Heart Disease: Results from the AtheroGene Study

Tibor Kempf, Jan-Malte Sinning, Anja Quint, Christoph Bickel, Christoph Sinning, Philipp S. Wild, Renate Schnabel, Edith Lubos, Hans J. Rupprecht, Thomas Münzel, Helmut Drexler, Stefan Blankenberg, and Kai C. Wollert
Circ Cardiovasc Genet published March 31, 2009, doi:10.1161/CIRCGENETICS.108.824870 [Abstract]  

Editorials
A Gene-Centric Approach to Elucidating Cardiovascular Risk

Ruth McPherson
Circ Cardiovasc Genet 2009;2:3-6, doi:10.1161/CIRCGENETICS.109.848986 [Full text]